Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Opsens Inc T.OPS

Alternate Symbol(s):  OPSSF

OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. The Company supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

RE:RE:Look at the chart...

Your right prophetoffactz, current ops price a gift........glta  rate and reply

RE:Look at the chart...

Today's sell-off was a gift. The NASDAQ Biotech ETF is now up marginaly over the last 3 months. OPS is down about 34%.  rate and reply

Imagine Lithium Identifies a New Drilling Target Located Near Flagship Jackpot Property

J.C. St-Amour, President of Imagine commented, "This newly discovered area demonstrates the prospectivity of our very large land package. The team is very excited to test this newly identified zone. There is some ground cover in this area, so there is excellent potential for expansion of this dike along strike as well as potential for additional dikes in this area. The grab sample grades suggest it is a well mineralized dike that we intend to drill test in 2023." ...read more

Look at the chart...

In Feb 2021, Opsens has announced a bought deal offering at a price of 1.80$ per common share. The stock was at 1.97$ at the time. Take at the look at the stock chart after this deal...  rate and reply

RE:RE:RE:Purgation!

Awww....Thanks!....that means so much to me to get a compliment from a meaningless stranger like you!.....lol Listen and you might acutally learn something.....  rate and reply

RE:RE:Purgation!

Im awed by your great widom!  rate and reply

RE:Purgation!

Sounds like you are trying to convince yourself...its gonna do what its gonna do.....pretty much every bought deal works the same way and pretty much has the same effect on the stock price and pretty...read more

Purgation!

On our way to the highest volume of the year after that flushing out the coast will be clear. Hang on!  rate and reply

RE:Another reminder

Just chill....re posting press releases will not make the price go up....walk away from your computer and go shopping or go get a Tims and a donut....the price is beyond your control....you need to be...read more

Another reminder

QUEBEC CITY, Oct. 26, 2022 /CNW Telbec/ - OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company...read more

RE:Reminder for those who are tempted to sell

Stop selling and relax....we all know that you are a shareholder....its gonna do what its gonna do and nothing you post is gonna change that.....it tested the $1.90 which is normal and then it bumps...read more

Reminder for those who are tempted to sell

“Opsens is making major strides towards commercializing its transcatheter aortic valve replacement (TAVR) guidewire, the SavvyWire. The TAVR market is expected to grow at a 15% CAGR through 2025 (with...read more

RE:RE:RE:It will trade to the diluted price of $1.90 and below

A bit surprised at the price but , longer term , a sound business move . Cashed up and ready for production rollouts next year .   rate and reply

RE:RE:RE:It will trade to the diluted price of $1.90 and below

Too many cups of coffee or maybe not enough...lol....you just need to just chill.....yup it already traded today at the $1.90 and then it bounces for awhile....will see where it settles  rate and reply

RE:RE:It will trade to the diluted price of $1.90 and below

Obviously I meant OPS not CTS (too many things on the go). GLTA  rate and reply

RE:It will trade to the diluted price of $1.90 and below

My bet is that because of its potential, CTS will remain above $1.90 notwithstanding the lousy market. An economic slowdown in China, war in the Ukraine, etc. should have no bearing on the future for...read more

RE:RE:RE:secondary offering

Another downgrade is on the way!!  rate and reply

It will trade to the diluted price of $1.90 and below

it always does on a bought deal and this deal is really no different...how much below the $1.90 is to be seen....market being down today at open will not help the sentiment  rate and reply

RE:RE:RE:secondary offering

How can this go to $1.70 when the pros get a basement deal at 1.90$ you are just a manipulator and im putting you on my ignore list.  rate and reply

RE:RE:secondary offering

We may see 1.7$ tomorrow!! Does the bought deal imply that our current closing price is too expensive!!   rate and reply